389 results about "Western blot" patented technology

The invention belongs to the field of monoclonal antibodies, and particularly relates to a mouse anti-pelteobagrus fulvidraco IgM monoclonal antibody, a hybridoma cell strain secreting the monoclonal antibody and application, a CDR region of a heavy chain variable region of the mouse anti-pelteobagrus fulvidraco IgM monoclonal antibody comprises three sequences shown in SEQ ID NO.1-3, and a CDR region of a light chain variable region of the mouse anti-pelteobagrus fulvidraco IgM monoclonal antibody comprises three sequences shown in SEQ ID NO.4-6; the mouse anti-pelteobagrus fulvidraco IgM monoclonal antibody can be obtained by being secreted by a hybridoma cell strain PFM-1B7C12A1B2 with the preservation number of CCTCC (China Center for Type Culture Collection) NO: C2024234. The mouse anti-pelteobagrus fulvidraco IgM monoclonal antibody provided by the invention can be used for Western blot and ELISA specific detection of IgM in a pelteobagrus fulvidraco secretion form, and can be used for flow cytometry identification of pelteobagrus fulvidraco IgM + B cells. The monoclonal antibody is good in specificity, high in sensitivity and strong in affinity, can be used for structural analysis, immune response level detection and the like of pelteobagrus fulvidraco IgM, and lays a foundation for in-depth study of a pelteobagrus fulvidraco immune system and establishment of a vaccine immune effect evaluation method taking the antibody level as an index.

The invention discloses a monoclonal antibody BY017 combined with African swine fever virus P30 protein and application of the monoclonal antibody BY017. The invention provides an IgG antibody which is composed of a light chain and a heavy chain. CDR1, CDR2 and CDR3 in the heavy chain variable region are sequentially shown as the 47 to 54 , the 72 to 79 and the 118 to 126 in SEQ ID NO: 1; cDR1, CDR2 and CDR3 in a light chain variable region are sequentially as shown in the 49 to 60 , the 78 to 80 and the 117 to 124 in SEQ ID NO: 3. The invention also protects the application of any one of the IgG antibodies in preparation of products. The product has the functions that the product is used for being combined with an African swine fever virus P30 protein fragment; the antibody is used for binding African swine fever virus P30 protein; the antibody is used for binding African swine fever virus. The IgG antibody provided by the invention can be used for multiple purposes of western blot, immunohistochemistry, flow cytometry, ELISA (Enzyme-Linked Immunosorbent Assay) and the like, and can be used as an important tool for ASFV detection and structural analysis of P30 protein of ASFV detection.

The invention relates to the technical field of spermidine application, in particular to application of spermidine in preparation of medicine for preventing and treating doxorubicin-induced cardiotoxicity and myocardial aging. Cell proliferation experiments and mouse survival rate experiments show that spermidine can reduce death of myocardial cells and mice caused by adriamycin; a q-PCR experiment shows that spermidine can improve abnormal expression conditions of P53, P21, P16, BAX, TNF-alpha, IFN alpha, IL-10 and IL-18 in myocardial cells caused by adriamycin; a beta-galactosidase staining experiment shows that the spermidine can reduce the condition that the expression of a marker beta-galactosidase for myocardial cell senescence induced by adriamycin is increased; a Western Blot experiment shows that the spermidine can improve the condition that the P53 protein is abnormally increased due to the adriamycin; an Elisa experiment shows that spermidine can improve the condition that myocardial injury markers cTn-I and AST and inflammatory factors IL-1beta are abnormally increased due to adriamycin, and the myocardial injury markers cTn-I and AST and inflammatory factors IL-1beta are abnormally increased due to adriamycin. Therefore, spermidine can improve cardiotoxicity and myocardial aging induced by adriamycin.

The invention belongs to the field of biological pharmacy, and relates to a temperature-sensitive hydrogel, in particular to a temperature-sensitive hydrogel SV (at) HP based on hyaluronic acid as well as a preparation method and application of the temperature-sensitive hydrogel SV (at) HP. The temperature-sensitive hydrogel SV (at) HP entraps CS-siRNA nanoparticles and VEGF (at) PLGA microspheres, and is used for realizing microenvironment responsive drug delivery to treat intrauterine adhesion. Chlorogenic acid and TGF beta1 siRNA are self-assembled through disulfide bonds to form CS-siRNA nano-particles, the CS-siRNA nano-particles are used for treating intrauterine adhesion through gene and chemical therapy, and cell and animal experiments prove that the CS-siRNA nano-particles have a good effect of improving intrauterine adhesion. Through evaluation of a real-time fluorescence quantification method, a western blot method, a cell scratch experiment, laser confocal microscope observation, inverted fluorescence microscope observation, an in-vivo experiment and the like, the SV-coated HP gel has the effects of resisting inflammation, improving endometrial fibrosis, promoting IUA rat endometrial angiogenesis and repair, inhibiting intrauterine adhesion and improving the intrauterine environment.

The invention relates to a Fenton-like oxidation treatment method, in particular to application of a self-activated Fenton-like composite repair material, the composite repair material is CaO2 (at) Fe3O4 (at) BIP-BC, western blot biochar is used as a matrix, and magnetite and calcium peroxide are sequentially loaded on the surface of the matrix. Compared with the prior art, the method has the advantages that the high efficiency and the long-term effect of Fenton-like are improved through biochar surface active groups and calcium peroxide, the selectivity of removing target harmful bacteria and harmful bacteria genes is improved through western blot, and the activating agent and the oxidizing agent are added at the same time, so that the use cost and the operation complexity are reduced. According to the method, the defects that traditional Fenton-like oxidation treatment is poor in harmful bacterium and harmful bacterium gene obligate removal effect, short in treatment time, high in required dosage and serious in secondary pollution, and an activating agent and an oxidizing agent need to be used separately are effectively overcome; the efficient and long-acting remediation of soil and water bodies polluted by harmful bacteria and harmful bacteria genes through the Fenton-like reaction is realized.

The monoclonal antibody of the glycoprotein Gn of the severe fever with thrombocytopenia syndrome virus is screened on the basis of immune repertoire sequencing, and the biological characteristics of the monoclonal antibody are identified. The method comprises the following steps: taking purified SFTSV-Gn as bait, taking virus specific B cells from an immunized female BALB / c mouse B cell bank, selecting an antibody sequence with potential binding activity by utilizing a 10 * immune repertoire sequencing method in combination with bioinformatics analysis, constructing the antibody sequence to an eukaryotic expression vector pcDNA3.4, expressing and purifying a monoclonal antibody, and identifying the biological activity of the monoclonal antibody. 14 antibodies are selected from 3544 captured B cells, functional verification shows that 12 antibodies can be combined with SFTSV-Gn glycoprotein, and the Gn-5 antibody and the Gn-7 antibody have high combining capacity; western blot, indirect immunofluorescence test and flow cytometry prove that the antibody can specifically recognize the SFTSV, the effective concentration is as low as 2 mu g / mL, and a foundation is laid for development of a rapid diagnosis reagent for the SFTSV.

The invention discloses an anti-CD3D antibody and application thereof.The antibody comprises a heavy chain variable region and a light chain variable region, the amino acid sequence of CDR-H1 of the heavy chain variable region is shown as SEQ ID NO: 4, the amino acid sequence of CDR-H2 of the heavy chain variable region is shown as SEQ ID NO: 5, and the amino acid sequence of CDR-H3 of the heavy chain variable region is GDL; the amino acid sequence of the CDR-L1 of the light chain variable region is as shown in SEQ ID NO: 6, the amino acid sequence of the CDR-L2 of the light chain variable region is as shown in SEQ ID NO: 7, and the amino acid sequence of the CDR-L3 of the light chain variable region is as shown in SEQ ID NO: 8. The anti-CD3D antibody is a rabbit monoclonal antibody, the obtained antibody is high in titer, clear in specific positioning in immunohistochemical staining and free of non-specific background staining, the antibody is wide in application, and the antibody can be used in pathological immunohistochemical staining experiments and can also be used in Western blot and flow cytometry experiments.

The invention discloses a novel nano-drug as well as a preparation method and application thereof, and co-delivery of siRNA and 3BP is realized on an exosome nano-platform, so that a novel nano-drug Exo (at) siRNA / 3BP-CTX (ERBC) engineering exosome is generated. The surface-modified cetuximab (CTX) is targeted to tumors, and shows high targeting and low toxicity in imaging analysis. CCK-8, western blot and immunofluorescence detection are used for detecting the tumor killing effect and the synergistic effect. The ERBC finds that the occurrence of death-promoting autophagy in KRAS mutation tumors is promoted on the transmission electron microscope (TEM) and molecular level.

The invention provides a method for constructing an MDA-MB-231 cell strain for expressing moesin-EGFP (Enhanced Green Fluorescent Protein). According to the method, sgRNA of a targeted moesin gene terminator region is designed, a Donor plasmid containing LHA, Linker, EGFP and RHA sequences is constructed, and a connecting sequence is added between a moesin protein and an EGFP protein by the plasmid, so that the influence of the EGFP on the function of the moesin protein is avoided. The sgRNA, the Cas9 protein and the linearized Donor plasmid are jointly transferred into the MDA-MB-231 cell by utilizing a CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats-associated protein 9) gene editing technology. According to the method, homozygote cells for expressing moesin-EGFP (enhanced green fluorescent protein) are sorted through flow cytometry, and gene editing and protein expression conditions are verified through PCR (polymerase chain reaction) and Western blot. According to the method, stable expression of the moesin-EGFP fusion protein is achieved, and the purpose of monitoring endogenous moesin expression in cells in real time is achieved. The cell strain can be used for researching the function of moesin in cell migration and signal transduction, and has a wide application prospect.

The invention belongs to the technical field of cell culture, and particularly relates to a culture method for in-vitro amplification of NK cells activated by NK cell exosomes, which comprises the following steps of: after promoting the NK cells to generate a large amount of exosomes by using an electrical stimulation method, filtering, performing ultrafiltration, extracting and purifying the NK cell exosomes by using specific immunomagnetic beads, thereby obtaining the NK cell exosomes activated by the NK cell exosomes. A set of strict detection and quantification standards is established for the exosome by utilizing Western Blot, a BCA method, DLS and NTA technical means, a primary PBMC is obtained by adopting a density gradient centrifugation method, and the high-activity and high-purity NK cell exosome is dynamically added into a cell culture medium in the activation and amplification stages of the PBMC, so that self-activation of the NK cells is realized, the proliferation efficiency of the NK cells is remarkably improved, and the NK cell exosome has a good application prospect. Meanwhile, the safety risk of a culture system is reduced.

The invention belongs to the technical field of image processing, and discloses a western blot image generation forgery detection method and system, a terminal and a storage medium, and the method comprises the steps: obtaining a to-be-detected image; wherein the to-be-detected image comprises a face image and a western blot image; performing feature extraction on the to-be-detected image based on a counterfeit detection model to obtain visual features; performing generation discrimination on the visual features to obtain a real discrimination result or a counterfeit discrimination result of the to-be-detected image; source discrimination is carried out on the visual features corresponding to the counterfeit discrimination result, and a discrimination result that the to-be-detected image comes from the face image or the western blot image is obtained; and outputting the western blot image to generate a forgery detection result. According to the method, the forgery recognition precision of the western blot image is improved, and the generalization ability of image forgery detection is enhanced.

The invention relates to the technical field of biology, and particularly discloses a construction method and application of an endometrial epithelium organ fibrosis model. According to the method, human endometrial epithelial cells are extracted, and an endometrial epithelial organ is established by adopting a Matrigel three-dimensional culture system. Afterwards, the organoid is induced to form endometrial phenotypes in different physiological cycles through hormone stimulation, and a ferroptosis inducer FIN56 is added in the culture process to induce fibrosis. The expression of GPX4, Fibronectin and p-Smad2 / 3 is detected through Western blot and immunofluorescence, and the successful construction of the fibrosis model is verified. The invention provides an in-vitro model capable of simulating endometrial fibrosis pathological characteristics of a patient with PCOS (polycystic ovarian syndrome), the in-vitro model can be used for mechanism research and drug screening of PCOS-related endometrial lesions, and a new research tool and an intervention strategy are provided for treatment of PCOS endometrial fibrosis.

The invention relates to a Fenton-like composite material, in particular to a self-activated Fenton-like composite repair material as well as a preparation method and application thereof, the composite repair material is CaO2 (at) Fe3O4 (at) BIP-BC, western blot biochar is taken as a matrix, and magnetite serving as an activating agent and calcium peroxide serving as a slow-release oxidizing agent are sequentially loaded on the surface. Compared with the prior art, the method has the advantages that the efficiency and the long-term effect of Fenton-like are improved through the biochar surface active groups and the calcium peroxide, the selectivity of removing target harmful bacteria and harmful bacteria genes is improved through western blot, and the biochar loads the calcium peroxide and the magnetite at the same time, so that an activating agent and an oxidizing agent are added at the same time; and the use cost and the operation complexity are reduced. The method overcomes the defects that the traditional Fenton-like oxidation treatment has poor obligate removal effect on harmful bacteria and harmful bacteria genes in the environment, the treatment time is short, the required dosage is high, the secondary pollution is serious, and an activating agent and an oxidizing agent need to be used separately.

The invention relates to the technical field of vaccines, in particular to an activity detection method of an HPV (human papilloma virus) trivalent therapeutic vaccine. The method comprises the following steps: inoculating and infecting BEAS-2B cells by adopting constructed HPV16 / 18 / 52 type E6 / E7 antigen-loaded non-replicating type 5 adenovirus, culturing, extracting total protein, sequentially performing SDS-PAGE (Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis), western blot detection, immunoreaction and developing imaging, and detecting the fusion protein; the transfection complex number MOI of the constructed adenovirus is 15-25, and the convergence degree of BEAS-2B cells is greater than 80%; the membrane transfer current of the western blot method is 220-280 mA, and the time is 50-80 minutes. The method avoids the problem of inaccurate detection results caused by obvious difference of biological activities in different animal species, has good accuracy, stability and durability, is simple in steps and low in cost, and can be effectively popularized and used.

The invention relates to the technical field of biological medicines, and particularly discloses a transcription factor HOMEZ phosphorylation site specific antibody as well as a preparation method and application thereof. The specific antibody provided by the invention can specifically recognize phosphorylation of the 451st site threonine of HOMEZ in a tumor specimen, so that the prognosis condition of the tumor is judged, and a potential action target is provided for clinical diagnosis and treatment of the tumor; moreover, the specific antibody disclosed by the invention can be used for detecting the expression difference between normal cells and tumor cells in a Western blot experiment, and is beneficial to research on the effect of phosphorylation modification of HOMEZ protein in the occurrence and development process of tumor diseases; and the kit can also be used for detecting the phosphorylation level of the HOMEZ protein in a clinical specimen through experiments such as immunofluorescence and immunohistochemical staining, and has a wide clinical application prospect in the aspects of disease diagnosis, treatment, prognosis judgment and the like.

The invention relates to the technical field of insulin resistance, in particular to an insulin resistance method for promoting a signal channel based on CTRP9. The method comprises the following steps: constructing a human hepatocyte line plasmid; carrying out cell culture and transfection; detecting the influence of CTRP9 on LO human hepatocyte glucose uptake, PGC-1a gene expression and the phosphorylation level of insulin signal channel related protein; detecting the influence of CTRP9 on glucose uptake of an LO human hepatocyte insulin resistance model, PGC-1a gene expression and the phosphorylation level of insulin signal channel related protein; and carrying out SirT1 / PGC-1a protein expression detection. According to the insulin resistance method for promoting the signal channel based on the CTRP9, a human hepatocyte line is taken as an in-vitro research object, an in-vivo research environment is simulated, a corresponding insulin resistance model is established, and the insulin resistance can be obtained by using technologies such as flow cytometry analysis, RT-PCR (Reverse Transcription-Polymerase Chain Reaction), western blotting and signal channel inhibition. And the treatment effect of CTRP9 on hepatic cell insulin resistance and the specific action mechanism are researched.

The invention provides a method for detecting the influence of drug-containing serum of Sijunzi decoction on hepatic stem cells. The method comprises the steps of cell culture, drug-containing serum preparation, cell proliferation experiment, cell damage model establishment and treatment, oxidative stress related index detection, protein expression analysis and the like. According to the method, cell activity is detected through a CCK-8 method, cell nucleus morphological change is observed through Hoechst 33342 staining, the apoptosis rate is detected through Annexin V / PI double staining in combination with flow cytometry, apoptosis-related protein expression is detected through Western blot, and the action mechanism of the drug-containing serum is comprehensively evaluated. Experimental results show that the drug serum of the Sijunzi decoction can promote proliferation of liver stem cells, reduce oxidative stress injury induced by H2O2, improve cell viability and oxidation resistance, reduce cell apoptosis rate, up-regulate expression of anti-apoptotic protein Bcl-2 and inhibit expression of pro-apoptotic protein Bax and Cleaved Caspase-3 at the same time.

The invention provides a deep learning-based marine mussel protein Western blot quantitative detection method. The deep learning-based marine mussel protein Western blot quantitative detection method comprises the following steps: preparing a marine mussel protein expression detection system: marine mussel collection, protein extraction, Western blot system optimization and marine mussel Western blot glue map collection; classification and identification model weight parameter training: constructing a database based on an existing Western blot glue chart, distinguishing target stripes in the Western blot glue chart, and training weight parameters of a target stripe identification model; and carrying out protein expression relative quantitative analysis based on the training model: carrying out original input Western blot gel chart preprocessing and identification, and carrying out protein expression quantitative calculation. According to the method, the stability and the credibility of the marine mussel protein Western blot quantitative detection are improved through the combination of an efficient protein extraction method and a Western blot detection system, and the analysis flux and the detection efficiency are greatly improved through a Western blot gel diagram processing analysis method based on deep learning.

The invention belongs to the technical field of biology, and particularly discloses an application of vinetulaABT-199 in preparation of drugs for preventing and treating akabane viruses, and the vinetulaABT-199 is used as a unique active component in prevention and treatment of the akabane viruses. Through determination of CC50 values and IC50 values in cells and healthy cells after akabane virus infection, it is found that Vinetura can be used as an akabane virus inhibitor. Furthermore, Western blot finds that the vinetura has a good inhibition effect on the akabane virus when the concentration is 1-10 [mu] M, and almost completely inhibits the replication of the akabane virus when the concentration reaches 10 [mu] M, thereby providing a new candidate drug for preventing and treating the akabane virus.

The invention discloses an immunoblotting data classification system based on feature engineering, relates to the technical field of data processing, and solves the problem that whether a protein band exists in an original immunoblotting image is difficult to identify; secondly, feature parameters of an original immunoblotting image and immunoblotting data are difficult to extract; secondly, a feature matrix is difficult to generate according to the feature parameters, and data classification is difficult to carry out after feature subsets are screened out according to a selection algorithm; and finally, the characteristic parameters in the characteristic subsets are difficult to comprehensively analyze. The system comprises the following modules: a data acquisition module, a data processing module, a feature extraction module, a feature processing module, a data classification module and a data analysis module. Through feature engineering and a classification model, classification of immune data is realized.

The invention discloses a monoclonal antibody BY013 combined with African swine fever virus P30 protein and application of the monoclonal antibody BY013. The invention provides an IgG antibody which is composed of a light chain and a heavy chain. CDR1, CDR2 and CDR3 in the heavy chain variable region are sequentially shown as the 47 to 54 , the 72 to 79 and the 118 to 130 in SEQ ID NO: 1; cDR1, CDR2 and CDR3 in a light chain variable region are sequentially as shown in the 49 to 60 , the 78 to 80 and the 117 to 124 in SEQ ID NO: 3. The invention also protects the application of any one of the IgG antibodies in preparation of products. The product has the functions that the product is used for being combined with an African swine fever virus P30 protein fragment; the antibody is used for binding African swine fever virus P30 protein; the antibody is used for binding African swine fever virus. The IgG antibody provided by the invention can be used for multiple purposes of western blot, immunohistochemistry, flow cytometry, ELISA (Enzyme-Linked Immunosorbent Assay) and the like, and can be used as an important tool for ASFV detection and structural analysis of P30 protein of ASFV detection.

The invention relates to an application of a THBS4 inhibitor in preparation of a medicine for preventing and / or treating pulmonary arterial hypertension. Three pulmonary arterial hypertension rat models (a hypoxia induction model, a hypoxia combined SUGEN induction model and a monocrotaline induction model) are constructed, the expression change of THBS4 is verified through qRT-PCR and western blot, and the correlation between the expression level of THBS4 and pulmonary arterial hypertension is verified in combination with in-vitro cell experiments and in-vivo intervention. Results show that THBS4 is remarkably up-regulated in pulmonary arteries of the three models, the expression level of THBS4 is positively correlated with the severity of diseases, and THBS4 is an important regulatory factor for promoting vascular remodeling in pulmonary arterial hypertension. In vivo, by knocking down THBS4, pulmonary vascular remodeling and right ventricular hypertrophy are remarkably relieved, and it is prompted that THBS4 inhibitors show good application prospects in the aspect of preventing and / or treating pulmonary arterial hypertension.

The invention discloses a construction and verification method of an HEK293T cell line capable of stably overexpressing human ANT2, which comprises the following steps: cloning a human ANT2 gene, constructing the human ANT2 gene into a lentivirus expression plasmid pLVX-TRE3G, co-transfecting the lentivirus expression plasmid pLVX-TRE3G and a helper plasmid pLVX-Tet3G into an HEK293T-ACE2 cell, and carrying out puromycin and G418 pressurized screening and Western blot identification to obtain the HEK293T cell line capable of stably overexpressing human ANT2. A result shows that the expression quantity of the ANT2 is the highest when the HEK293T-ACE2-ANT2 cell is induced for 12 hours at the Doxycycline of 6mg / L; when the ANT2 is induced to express, the virus nucleic acid load and the N protein expression level after SARS-CoV-2 infection are obviously reduced, which indicates that the ANT2 has an inhibition effect on SARS-CoV-2 infection replication, and a cell model and an experimental basis are provided for exploring the effect of the ANT2 in virus infection resistance.

The invention provides application of ginsenoside Re carbon nanodots in the field of preparation of pharmaceutical preparations for resisting kidney cancer and / or inhibiting kidney cancer A498 cells. The ginsenoside Re carbon nanodots (Re-CDs) prepared by the invention have the characteristics of uniform particle size distribution, good water solubility, low biotoxicity, high cell membrane permeability and the like, also have good time, pH value and salt stability, and particularly have a relatively high inhibition effect on kidney cancer A498 cells and kidney cancer, whether in vitro or in vivo. Through transcriptomics detection, qPCR (quantitative polymerase chain reaction) verification, immunofluorescence detection and Western blot methods, a molecular mechanism of the Re-CDs anti-A498 cell is disclosed on the cellular level. The result shows that the Re-CDs can promote the cycle arrest and apoptosis of the A498 cells through the PI3K / AKT signal channel. The invention provides a new research strategy for anti-kidney cancer treatment based on CDs nano medicine in the future.

The invention discloses an FLG gene and protein detection method based on oral cell non-invasive sampling, which comprises the following steps: Step 1: sample collection: collecting oral cells through mouth rinsing of a subject; step2: RNA extraction and gene expression analysis: extracting oral cell total RNA in the oral cells in the step 1 by using a Trizol reagent, and analyzing FLG gene expression through qRT-PCR (Quantitative Reverse Transcription-Polymerase Chain Reaction); 3, protein extraction and immunoblotting analysis are conducted, specifically, protein is extracted from the oral cells in the step 1 through an SDS lysis buffer solution, and FLG protein expression is detected through the Western blot technology. According to the present invention, the subject rinses the mouth and collects the oral cavity cells, such that the convenient, non-invasive and efficient sample collection is achieved.

The invention provides an immunofluorescence detection method and system for dynamically detecting mouse uterus structure development based on multiple time points, and immunofluorescence staining comprises the steps of sheet unfolding, dewaxing, repairing, cell membrane punching, sealing, primary antibody treatment and secondary antibody treatment. The system comprises a sample pretreatment control module, a multi-channel confocal microscope imaging module and a data analysis module integrating fluorescence intensity calculation, Pearson co-localization analysis and a Western blot data integration algorithm. Through a multi-time-point and multi-index immunofluorescence detection method, dynamic and systematic data support is provided for mouse uterus development mechanism research, and an application basis is provided for fundamental research of reproductive biology and construction of related disease models.

The present invention belongs to the technical field of in vitro cell differentiation. The present invention provides a method, composition and application for separation, identification and adipogenic differentiation of mammalian adipocytes. The mechanical method combined with collagenase digestion method is used to successfully separate and obtain mammalian adipocytes. Immunofluorescence technology is used to identify the obtained adipocytes. The adipogenic differentiation method of adipocytes is explored by a combination of multiple adipogenic induction factors. The differentiated mature adipocytes are identified by Oil Red O staining, BODIPY staining, triglyceride (TAG) content determination and / or Western blot technology. The results show that the adipogenic differentiation method of the present invention has good beneficial effects, is an ideal method for studying adipocyte differentiation, and has important application value in the fields of animal husbandry, biomedicine and biological meat cultivation.

The invention relates to the technical field of biological medicines, and discloses a blocking antibody targeting CXCL6 and an application of the blocking antibody in preparation of antitumor drugs. The antibody or antigen-binding fragment thereof is capable of binding specifically to human CXCL6 protein with high affinity (e.g., Kd < = 1 nM). According to the invention, the specificity and high affinity of the antibody are verified by Western Blot, immunofluorescence, immunohistochemistry and surface plasmon resonance (SPR) technologies. Functional experiments show that the antibody can effectively block CXCL6-induced neutrophil chemotaxis, including in Transwell, a three-dimensional gel model and a zebra fish living body model. Besides, in a mouse MC38 colon cancer model, the antibody shows remarkable anti-tumor activity and can inhibit tumor growth driven by CXCL6. The invention also provides a pharmaceutical composition containing the antibody, and application of the antibody in preparation of drugs for preventing or treating diseases (such as inflammatory diseases, autoimmune diseases and cancers) related to abnormal expression or activity of CXCL6.

The present application relates to the technical field of biotechnology, in particular to a programmed death receptor ligand 2 monoclonal antibody and application thereof. The present application provides a PD-L2 monoclonal antibody, amino acid sequences of three CDR regions of a heavy chain thereof; amino acid sequences of three CDR regions of a light chain thereof; or amino acid sequences obtained by substitution, deletion or addition of one or more amino acids of the amino acid sequences, or amino acid sequences functionally identical or similar to the amino acid sequences; or amino acid sequences having at least 80% homology with the sequences. The present application widens the possibility of antibody therapy for blocking PD1 / PD1 ligand, and compared with existing PD-L2 monoclonal antibodies, the 8E3 antibody has unique amino acid sequences and CDR region sequences, high affinity and high specificity. The 8E3 antibody can be used in ELISA, Western blot and flow cytometry detection, and has wide application.

The invention discloses application of a PRTFDC1 gene in promoting porcine skeletal muscle satellite cell differentiation, myotube formation and skeletal muscle development. According to the invention, overexpression and knock-down experiments of the PRTFDC1 are respectively carried out in pig MuSCs, and immunofluorescence, qRT-PCR and Western blot analysis are carried out on cells subjected to induced differentiation, so that the PRTFDC1 is effectively shown to play a positive regulation role in a pig MuSCs differentiation process, and a new marker gene which can be applied to pig molecular breeding and growth performance evaluation is provided; and a novel molecular target and a novel detection tool are provided for muscle development regulation and biological breeding.